Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Interest Expenses (2016 - 2022)

Historic Interest Expenses for BioRestorative Therapies (BRTX) over the last 11 years, with Q3 2022 value amounting to $28841.0.

  • BioRestorative Therapies' Interest Expenses fell 9417.99% to $28841.0 in Q3 2022 from the same period last year, while for Jun 2023 it was $28841.0, marking a year-over-year decrease of 9417.99%. This contributed to the annual value of $177286.0 for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q3 2022, BioRestorative Therapies' Interest Expenses is $28841.0, which was down 9417.99% from $495545.0 recorded in Q3 2021.
  • BioRestorative Therapies' Interest Expenses' 5-year high stood at $495545.0 during Q3 2021, with a 5-year trough of $6769.0 in Q2 2020.
  • Its 4-year average for Interest Expenses is $137558.8, with a median of $23960.5 in 2019.
  • Data for BioRestorative Therapies' Interest Expenses shows a peak YoY increase of 9417.99% (in 2022) and a maximum YoY decrease of 9417.99% (in 2022) over the last 5 years.
  • Over the past 4 years, BioRestorative Therapies' Interest Expenses (Quarter) stood at $19080.0 in 2019, then crashed by 64.52% to $6769.0 in 2020, then skyrocketed by 7220.8% to $495545.0 in 2021, then tumbled by 94.18% to $28841.0 in 2022.
  • Its Interest Expenses was $28841.0 in Q3 2022, compared to $495545.0 in Q3 2021 and $6769.0 in Q2 2020.